These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 7491134)
1. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. Lackritz EM; Satten GA; Aberle-Grasse J; Dodd RY; Raimondi VP; Janssen RS; Lewis WF; Notari EP; Petersen LR N Engl J Med; 1995 Dec; 333(26):1721-5. PubMed ID: 7491134 [TBL] [Abstract][Full Text] [Related]
2. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ; Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173 [TBL] [Abstract][Full Text] [Related]
3. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. Schreiber GB; Busch MP; Kleinman SH; Korelitz JJ N Engl J Med; 1996 Jun; 334(26):1685-90. PubMed ID: 8637512 [TBL] [Abstract][Full Text] [Related]
5. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Busch MP; Glynn SA; Stramer SL; Strong DM; Caglioti S; Wright DJ; Pappalardo B; Kleinman SH; Transfusion; 2005 Feb; 45(2):254-64. PubMed ID: 15660836 [TBL] [Abstract][Full Text] [Related]
6. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779 [TBL] [Abstract][Full Text] [Related]
7. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges. Lackritz EM AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988 [TBL] [Abstract][Full Text] [Related]
8. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [TBL] [Abstract][Full Text] [Related]
9. [HIV retrospective study of the German Red Cross blood donation service in Germany]. Glück D; Elbert G; Dengler T; Gossrau E; Grässmann W; Grimm M; Holzberger G; Sternberger J; Weise W; Kubanek B Infusionsther Transfusionsmed; 1994 Dec; 21(6):368-75. PubMed ID: 7873915 [TBL] [Abstract][Full Text] [Related]
10. Transfusion-associated human immunodeficiency virus type 1 from screened antibody-negative blood donors. Roberts CR; Longfield JN; Platte RC; Zielmanski KP; Wages J; Fowler A Arch Pathol Lab Med; 1994 Dec; 118(12):1188-92. PubMed ID: 7979912 [TBL] [Abstract][Full Text] [Related]
11. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy. Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219 [TBL] [Abstract][Full Text] [Related]
12. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP; N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889 [TBL] [Abstract][Full Text] [Related]
13. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. Ward JW; Holmberg SD; Allen JR; Cohn DL; Critchley SE; Kleinman SH; Lenes BA; Ravenholt O; Davis JR; Quinn MG N Engl J Med; 1988 Feb; 318(8):473-8. PubMed ID: 3422337 [TBL] [Abstract][Full Text] [Related]
14. Risk of HIV infection from blood transfusion in Montreal. Remis RS; Delage G; Palmer RW CMAJ; 1997 Aug; 157(4):375-82. PubMed ID: 9275944 [TBL] [Abstract][Full Text] [Related]
15. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil. Maresch C; Schluter PJ; Wilson AD; Sleigh A Transfusion; 2008 Feb; 48(2):273-81. PubMed ID: 18005323 [TBL] [Abstract][Full Text] [Related]
16. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Shang G; Seed CR; Wang F; Nie D; Farrugia A Transfusion; 2007 Mar; 47(3):529-39. PubMed ID: 17319836 [TBL] [Abstract][Full Text] [Related]
17. Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil. Barreto CC; Sabino EC; Gonçalez TT; Laycock ME; Pappalardo BL; Salles NA; Wright DJ; Chamone DF; Busch MP Transfusion; 2005 Nov; 45(11):1709-14. PubMed ID: 16271094 [TBL] [Abstract][Full Text] [Related]
18. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors? Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP; Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352 [TBL] [Abstract][Full Text] [Related]
19. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Zou S; Dorsey KA; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY; Stramer SL Transfusion; 2010 Jul; 50(7):1495-504. PubMed ID: 20345570 [TBL] [Abstract][Full Text] [Related]
20. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. Zou S; Dodd RY; Stramer SL; Strong DM; N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]